SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-19-024633
Filing Date
2019-11-25
Accepted
2019-11-25 17:29:51
Documents
2
Group Members
VIVO CAPITAL IX, LLCVIVO VENTURES VII, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g1119vivocapital_sierra.htm SC 13G 109313
2 JOINT FILING AGREEMENT sc13g1119ex99-1vivo_sierra.htm EX-99.1 10837
  Complete submission text file 0001213900-19-024633.txt   121767
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Subject) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89009 | Film No.: 191247128
SIC: 2834 Pharmaceutical Preparations

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Opportunity, LLC (Filed by) CIK: 0001728970 (see all company filings)

IRS No.: 823132352 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G